Compare Aventis Pharma with Fresenius Kabi Onco. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs FRESENIUS KABI ONCO. - Comparison Results

SANOFI INDIA     Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

FRESENIUS KABI ONCO. 
   Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA FRESENIUS KABI ONCO. SANOFI INDIA/
FRESENIUS KABI ONCO.
 
P/E (TTM) x 44.1 22.1 199.3% View Chart
P/BV x 8.1 3.1 259.7% View Chart
Dividend Yield % 1.1 0.0 -  

Financials

 SANOFI INDIA   FRESENIUS KABI ONCO.
EQUITY SHARE DATA
    SANOFI INDIA
Dec-18
FRESENIUS KABI ONCO.
Mar-13
SANOFI INDIA/
FRESENIUS KABI ONCO.
5-Yr Chart
Click to enlarge
High Rs6,840176 3,886.4%   
Low Rs4,63079 5,898.1%   
Sales per share (Unadj.) Rs1,203.137.7 3,192.5%  
Earnings per share (Unadj.) Rs165.35.1 3,244.8%  
Cash flow per share (Unadj.) Rs209.96.7 3,121.4%  
Dividends per share (Unadj.) Rs84.000-  
Dividend yield (eoy) %1.50-  
Book value per share (Unadj.) Rs963.642.5 2,265.0%  
Shares outstanding (eoy) m23.03158.23 14.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.83.4 141.2%   
Avg P/E ratio x34.725.0 138.9%  
P/CF ratio (eoy) x27.318.9 144.4%  
Price / Book Value ratio x6.03.0 199.0%  
Dividend payout %50.80-   
Avg Mkt Cap Rs m132,07820,135 656.0%   
No. of employees `0003.31.2 286.5%   
Total wages/salary Rs m4,068703 578.5%   
Avg. sales/employee Rs Th8,393.85,176.2 162.2%   
Avg. wages/employee Rs Th1,232.4610.4 201.9%   
Avg. net profit/employee Rs Th1,153.0699.6 164.8%   
INCOME DATA
Net Sales Rs m27,7085,963 464.7%  
Other income Rs m89718 4,983.3%   
Total revenues Rs m28,6055,981 478.3%   
Gross profit Rs m6,2351,430 436.0%  
Depreciation Rs m1,027258 398.2%   
Interest Rs m7-26 -26.9%   
Profit before tax Rs m6,0981,216 501.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-68 0.0%   
Tax Rs m2,292342 669.8%   
Profit after tax Rs m3,806806 472.3%  
Gross profit margin %22.524.0 93.8%  
Effective tax rate %37.628.1 133.6%   
Net profit margin %13.713.5 101.6%  
BALANCE SHEET DATA
Current assets Rs m15,9225,102 312.1%   
Current liabilities Rs m6,2352,385 261.4%   
Net working cap to sales %35.045.6 76.8%  
Current ratio x2.62.1 119.4%  
Inventory Days Days64150 42.4%  
Debtors Days Days21113 18.4%  
Net fixed assets Rs m7,5395,148 146.4%   
Share capital Rs m230158 145.4%   
"Free" reserves Rs m21,9626,556 335.0%   
Net worth Rs m22,1926,732 329.7%   
Long term debt Rs m0952 0.0%   
Total assets Rs m29,83910,388 287.2%  
Interest coverage x872.1-45.8 -1,905.2%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.90.6 161.8%   
Return on assets %12.87.5 170.2%  
Return on equity %17.212.0 143.3%  
Return on capital %27.514.6 188.4%  
Exports to sales %074.5 0.0%   
Imports to sales %024.8 0.0%   
Exports (fob) Rs mNA4,441 0.0%   
Imports (cif) Rs mNA1,477 0.0%   
Fx inflow Rs m7,5875,298 143.2%   
Fx outflow Rs m7,1451,772 403.2%   
Net fx Rs m4423,525 12.5%   
CASH FLOW
From Operations Rs m3,7391,274 293.5%  
From Investments Rs m-731-1,204 60.7%  
From Financial Activity Rs m-1,972-196 1,005.6%  
Net Cashflow Rs m1,036-126 -820.3%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 60.4 81.0 74.6%  
Indian inst/Mut Fund % 14.4 0.3 4,800.0%  
FIIs % 14.6 9.6 152.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 9.1 115.4%  
Shareholders   15,184 42,599 35.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   PANACEA BIOTECH  DIVIS LABORATORIES  FULFORD INDIA  NATCO PHARMA  ELDER PHARMA  

Compare SANOFI INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 178 Points Higher; Telecom and Power Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest throughout the day today and ended on a positive note.

Related Views on News

SANOFI INDIA Announces Quarterly Results (4QFY20); Net Profit Down 8.1% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, SANOFI INDIA has posted a net profit of Rs 854 m (down 8.1% YoY). Sales on the other hand came in at Rs 8 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY20); Net Profit Down 2.2% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, SANOFI INDIA has posted a net profit of Rs 974 m (down 2.2% YoY). Sales on the other hand came in at Rs 7 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY19); Net Profit Up 12.6% (Quarterly Result Update)

May 8, 2019 | Updated on May 8, 2019

For the quarter ended March 2019, SANOFI INDIA has posted a net profit of Rs 929 m (up 12.6% YoY). Sales on the other hand came in at Rs 7 bn (up 16.1% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA 2017-18 Annual Report Analysis (Annual Result Update)

Apr 16, 2019 | Updated on Apr 16, 2019

Here's an analysis of the annual report of SANOFI INDIA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SANOFI INDIA. Also includes updates on the valuation of SANOFI INDIA.

SANOFI INDIA Announces Quarterly Results (3QFY19); Net Profit Up 4.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, SANOFI INDIA has posted a net profit of Rs 793 m (up 4.3% YoY). Sales on the other hand came in at Rs 7 bn (up 8.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

More Views on News

Most Popular

Be Prepared to Profit from the Coming Crash in Oil Prices(Fast Profits Daily)

Jun 25, 2020

The stability in crude oil prices will not last much longer. Be ready to make fast profits when the time comes to short crude.

Tata Motors Tripled in 18 Months but You Can Do Even Better. Here's How...(Profit Hunter)

Jun 24, 2020

Rahul is ready for a repeat of his famous 2008 Tata Motors call.

The Triple Digit Return Opportunity in this Market

Jun 24, 2020

Rahul Shah on stocks with potentially triple digit returns.

This Ratio Says Smallcaps Are Your Best Bet to Ride the Post Covid Market Rebound(Profit Hunter)

Jun 23, 2020

Here's why I believe that post Covid rebound in smallcaps will be much sharper than largecaps.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Jul 3, 2020 03:35 PM

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA 5-YR ANALYSIS

COMPARE SANOFI INDIA WITH

MARKET STATS